InspiroGene by McKesson (“InspiroGene”) is a dedicated business unit focused solely on supporting the commercialization of cell and gene therapies (CGTs). At InspiroGene, we turn CGT innovation into a reality.
We offer flexible, sustainable solutions to help manufacturers, payers, and providers navigate the complex CGT commercialization landscape. As an enduring ally, we’re dedicated to transforming patient care and driving better health outcomes.
Learn more about the InspiroGene advantage at
Read the full
2024 Cell and Gene Therapy Report
from InspiroGene™ by McKesson
InspiroGene.com
About InspiroGene by McKesson